In October, the Accelerate Cure/Treatments for Alzheimer’s Disease (ACT-AD) coalition, which is chaired by the Alliance for Aging Research, attended the 11th Annual Clinical Trials on Alzheimer’s Disease (CTAD) conference in Barcelona, Spain. Missy Jenkins, Executive Director of ACT-AD and Vice President for Public Policy at the Alliance, summarized some of the major highlights from the conference here.